http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4534967-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2065ba26f01c8436c29d145028ed2336
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
filingDate 1982-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1985-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80ec7f67a0309ddf20259aafac61b74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_868ed57a2a6bcb2aad075dded6c4f314
publicationDate 1985-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4534967-A
titleOfInvention Cell proliferation inhibitor and method of preparation
abstract An inhibitor of endothelial cell growth is prepared by directly liquifying vitreous gel, as for example, forcing vitreous gel through a small orifice so as to directly convert the gel into a liquid, removing insoluble and suspended material and chromatographically fractionating the liquid and isolating the fractions. An inhibitor is also prepared by culturing hyalocyte cells in a medium and chromatographically fractionating the medium.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-590872-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4996159-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003096750-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901611-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7179621-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6350467-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820516-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0312246-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6319687-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451763-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8604783-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007281886-A9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006008900-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6204248-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0312246-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9409800-A1
priorityDate 1982-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE30239-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4042457-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4176177-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4217412-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4164560-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID352546

Total number of triples: 52.